The licensed indications for Searle's Elleste Duet Conti (estradiol 2mg [as hemihydrate], norethisterone acetate 1mg) tablets have been extended. Elleste Duet Conti is now additionally licensed for prophylaxis of postmenopausal osteoporosis in women at risk of developing fractures.